The White House has decided to withdraw the nomination of Dr. Heidi Overton as the Food and Drug Administration (FDA) commissioner. This decision was confirmed by a senior administration official and other sources familiar with the matter.
Dr. Overton was President Trump’s choice for the position. Her nomination was set to be reviewed by the Senate health committee, with a vote initially planned for Wednesday. The news of her withdrawal was first reported by Axios.
This development signals a significant change in the administration’s plans for the FDA leadership. Further details on the decision or the potential next steps for the nomination process have not yet been disclosed.
Updates will follow as more information becomes available.
